Proteon logo     Print Page | Close Window

SEC Filings

8-K
PROTEON THERAPEUTICS INC filed this Form 8-K on 08/07/2017
Entire Document
 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Proteon Therapeutics, Inc.  
       
       
Date: August 7, 2017 By:  /s/ George A. Eldridge  
    George A. Eldridge  
    Senior Vice President & Chief Financial Officer